Forte Research Systems Celebrates Record Year for OnCore® eClinical Solution

Nine leading clinical research institutions selected the OnCore^® system in 2012 to manage their clinical trials. 

Madison, Wis., January 10, 2012 - Forte Research Systems, a leading developer of specialized clinical trial management systems (CTMS) and eClinical solutions, is pleased to announce that a record-breaking number of clinical research institutions adopted the company's flagship product, the OnCore® eClinical solution, in 2012.

Nine institutions selected OnCore, with the majority implementing the system across multidisciplinary research groups:

• Medical College of Wisconsin
• University of Minnesota
• Levine Cancer Institute
• University of Illinois Cancer Center
• UC Irvine Health
• Indiana University
• Thomas Jefferson University
• Shriners Hospitals for Children
• Georgia Regents University

OnCore has long been established as the nation's most widely adopted enterprise-class eClinical solution among academic medical centers, research hospitals, and cancer centers. With the addition of the new customers in 2012, OnCore now supports the needs of 53 institutions around the country, including 24 cancer centers designated by the National Cancer Institute.

The rapid growth of the OnCore community reflects a trend among clinical research institutions to manage their trials with a centralized system. It further solidifies the position of the OnCore system as the trusted market leader.

"More than 50 leading clinical research institutions have chosen the OnCore system to manage and expand their robust portfolios of clinical trials," said Srini Kalluri, Founder, President, CEO, and Chief Customer Officer at Forte. "In today's environment of growing trial complexity and regulatory oversight, the need for a centralized system has never been greater and institutions are selecting OnCore to meet that need."

Tony O'Hare, Ph.D, Co-Founder and Chief Collaboration Officer at Forte, points to the company's commitment to product enhancement as a major contributor to the OnCore system's success. "Forte is committed to collaborating with customers to guide the development of the OnCore system," he said. "Because we listen to the customer community, ground-breaking integrations with electronic medical record software, the ClinicalTrials.gov registry database, and NCI's Clinical Trials Reporting Program have all been debuted this year. Additional enhancements introduced in 2012, such as a Coverage Analysis module for billing compliance, have strengthened the OnCore system and kept it the top eClinical solution in the industry."

Forte was recognized for additional achievements in 2012. It was ranked No. 1959 on Inc. magazine's sixth annual Inc. 500 5000, an exclusive ranking of the nation's fastest-growing private companies. It was the third consecutive year that Forte was ranked on the list. Forte was also listed as No. 303 on Deloitte's Technology Fast 500, a ranking of the fastest-growing technology companies in North America. The company achieved this ranking with a four-year revenue growth rate of 251 percent.

About Forte Research Systems, Inc.

With a strong belief that clinical research excellence begins with the sites, Forte Research Systems offers specialized products for clinical research operations.

OnCore^® is an on-premise, eClinical solution for the clinical research enterprise that fully integrates CTMS, EDC, data management, billing compliance, biospecimen management, and patient registry management functionality. The system has been developed to specifically address the needs of mid-sized to large research hospitals, cancer centers, academic medical centers, and CTSAs.

Allegro^®  systems are cloud-based CTMS that help manage study startup, study conduct, subject visits, budgets and financials. Allegro CTMS@Site is designed for investigator sites and research groups while Allegro CTMS@Network is designed for multi-site networks and site and trial management organizations.